Surface Plasmon Resonance for Determination of Potency.
Gaderer, S. (2022). Pharm. Ind. 84, Nr. 7, 909 – 917 (2022) © ECV • Editio Cantor Verlag, Aulendorf (Germany).
Insight into biosimilars: Short description, analytical assessment and market.
Zimmermann, K, Fido, M, and Roucka, M. (2020). Medical Research Archives 8: issue 3.
Glycosylation pattern of biotechnologically produced proteins – lectin array technology as a versatile tool for screening?
Zimmermann, K, Fido, M, and Roucka, M. (2018). Medical Research Archives 6: issue 3.
Application of lectin array technology for biobetter characterization: its correlation with FcγRIII binding and ADCC. Microarrays.
Roucka, M, Zimmermann, K, Fido, M, and Nechansky, A. (2017). 6:1.
Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection.
Zopf, A, Raim, R, Danzer, M, Niklas, N, Spilka, R, Pröll, J, Gabriel, C, Nechansky, A, and Roucka, M. (2015). Biotechniques. 58:126 – 134.
Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y‑specific monoclonal antibody MB314.
Kircheis, R, Halanek, N, Koller, I, Jost, W, Schuster, M, Gorr, G, Hajszan, K, and Nechansky, A. (2012). MAbs. 4:532 – 541.
Immunogenicity of therapeutics: a matter of efficacy and safety.
Nechansky, A, and Kircheis R. (2010). Drug Discov. 5:1 – 13.